Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in BRCA-1/2 Mutation Carriers
NCT01898312Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Sep 2013
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in breast cancer, sponsored by Karolinska Institutet. Started Sep 2013; status: completed.
02
Drugs
mifepristone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01898312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898312.